Mylan Inc. (NASDAQ:MYL) shares were higher over 2% recently after saying it has agreed to buy Abbot’s (ABT) non-U.S. developed markets…
Browsing: BioPharma
15
Mylan Inc. (NASDAQ:MYL) Buys Abbott’s Non-US Generic Pharma Business For $5.3 Bln in Stock
169
Sabra Health Care REIT Inc. (NASDAQ:SBRA) Agrees on Terms for the Origination of a $15.5 Million Mezzanine Loan
Sabra Health Care REIT Inc. (NASDAQ:SBRA), a self-administered, self-managed real estate investment trust, has announced the completion of two preferred…
539
The Female Health Company (NASDAQ:FHCO) Drops to 2-Year Low; Stops Dividend Payments
The Female Health Company (NASDAQ:FHCO) shares fell to their lowest level since March 2012 after saying it will suspend payment of…
14
Biotech Stocks Updates: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA)
Twenty-three market research firms that were covering Ariad Pharmaceuticals (NASDAQ:ARIA) stocks gave the stocks a consensus rating of ‘hold’ whereas…
239
Soaring Volume in Biotech: Lexicon Pharmaceuticals (NASDAQ:LXRX), Bluebird bio Inc (NASDAQ:BLUE), BioDelivery Sciences International, Inc. (NASDAQ:BDSI, Acasti Pharma (NASDAQ:ACST), Ultragenyx Pharmaceutical (NASDAQ:RARE)
According to the news, JDRF, the biggest non-profit supporter of research firms that conduct experiments on type 1 diabetes’ drugs,…
21
BioTech Stocks to Watch: Arrowhead Research (NASDAQ:ARWR) Is on Road to Recovery
Arrowhead Research (NASDAQ:ARWR) has been identified as the “dead cat bounce” nominee by Trade-Ideas LLC. This means than Arrowhead Research (NASDAQ:ARWR) has…